For the quarter ending 2026-03-31, MET-PF has $743,211M in assets. $715,410M in debts. $22,687M in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of 273 and 249, respectively) and amortized cost 342,191 and 337,201, respectively | 316,110 | 315,931 | 304,645 | 298,737 |
| Equity securities, at estimated fair value | 927 | 858 | 788 | 790 |
| Contractholder-directed equity securities and fair value option securities, at estimated fair value (includes 1,665 and 1,751, respectively, relating to variable interest entities) | 13,435 | 13,959 | 12,270 | 11,694 |
| Mortgage loans (net of allowance for credit loss of 1,213 and 1,193, respectively includes 35 and 35, respectively, of mortgage loans held-for-sale) | 83,726 | 84,593 | 85,843 | 86,868 |
| Policy loans | 8,455 | 8,547 | 8,589 | 8,664 |
| Real estate and real estate joint ventures (includes 303 and 378, respectively, under the fair value option 164 and 132, respectively, of real estate held-for-sale 376 and 302, respectively, relating to variable interest entities) | 13,356 | 13,440 | 13,932 | 14,007 |
| Other limited partnership interests | 14,531 | 14,917 | 14,741 | 14,279 |
| Short-term investments, principally at estimated fair value | 4,948 | 3,601 | 5,962 | 5,300 |
| Other invested assets (includes 1,586 and 1,698, respectively, of leveraged and direct financing leases 657 and 560, respectively, relating to variable interest entities) | 17,624 | 16,332 | 16,932 | 16,352 |
| Total investments | 473,112 | 472,178 | 463,702 | 456,691 |
| Cash and cash equivalents, principally at estimated fair value (includes 132 and 96, respectively, relating to variable interest entities) | 22,687 | 22,032 | 20,233 | 22,178 |
| Accrued investment income | 3,796 | 3,719 | 3,791 | 3,532 |
| Premiums, reinsurance and other receivables | 50,335 | 49,059 | 40,329 | 31,503 |
| Market risk benefits, at estimated fair value | 392 | 458 | 392 | 352 |
| Deferred policy acquisition costs and value of business acquired | 21,269 | 21,107 | 21,175 | 20,993 |
| Current income tax recoverable | 455 | 660 | 374 | 554 |
| Deferred income tax asset | 2,901 | 2,585 | 2,719 | 2,925 |
| Goodwill | 9,565 | 9,613 | 9,095 | 9,142 |
| Other assets | 11,013 | 11,822 | 11,572 | 11,425 |
| Separate account assets | 147,686 | 151,933 | 146,344 | 143,175 |
| Total assets | 743,211 | 745,166 | 719,726 | 702,470 |
| Future policy benefits | 206,628 | 208,855 | 199,169 | 198,965 |
| Policyholder account balances | 239,836 | 236,857 | 235,312 | 232,433 |
| Market risk benefits, at estimated fair value | 2,522 | 2,406 | 2,585 | 2,709 |
| Other policy-related balances | 20,444 | 20,070 | 20,361 | 19,899 |
| Policyholder dividends payable | 337 | 356 | 369 | 367 |
| Payables for collateral under securities loaned and other transactions | 18,157 | 17,115 | 17,139 | 17,147 |
| Short-term debt (includes 113 and 117, respectively, relating to variable interest entities) | 404 | 355 | 378 | 379 |
| Long-term debt (includes 68 and 28, respectively, relating to variable interest entities) | 14,445 | 14,467 | 15,300 | 15,374 |
| Collateral financing arrangement | 299 | 352 | 398 | 438 |
| Subordinated debt securities | 5,143 | 4,155 | 4,154 | 4,153 |
| Notes issued by collateralized financing entities (includes all amounts under the fair value option and relating to variable interest entities) | 1,138 | 1,206 | - | - |
| Deferred income tax liability | 382 | 536 | 574 | 430 |
| Other liabilities (includes 139 and 167, respectively, relating to variable interest entities) | 57,989 | 57,582 | 48,452 | 39,074 |
| Separate account liabilities | 147,686 | 151,933 | 146,344 | 143,175 |
| Total liabilities | 715,410 | 716,245 | 690,535 | 674,543 |
| Redeemable noncontrolling interests | 206 | 241 | - | - |
| Common stock, par value 0.01 per share 3,000,000,000 shares authorized 1,196,399,473 and 1,195,587,190 shares issued, respectively 646,024,938 and 655,333,773 shares outstanding,respectively | 12 | 12 | 12 | 12 |
| Additional paid-in capital | 32,921 | 32,858 | 32,855 | 33,822 |
| Retained earnings | 45,058 | 44,290 | 43,887 | 43,447 |
| Treasury stock, at cost 550,374,535 and 540,253,417 shares, respectively | 31,440 | 30,678 | 30,244 | 29,737 |
| Accumulated other comprehensive income (loss) | -19,227 | -18,084 | -17,566 | -19,859 |
| Total metlife, inc.s stockholders equity | 27,324 | 28,398 | 28,944 | 27,685 |
| Noncontrolling interests | 271 | 282 | 247 | 242 |
| Total equity | 27,595 | 28,680 | 29,191 | 27,927 |
| Total liabilities, mezzanine equity and equity | 743,211 | 745,166 | 719,726 | 702,470 |
METLIFE INC (MET-PF)
METLIFE INC (MET-PF)